Introduction
Findings
Materials and methods
Patient selection
In vitro tests: lymphocyte transformation test (LTT)
In vivo test: skin tests
Results
Patient | Age (years) | Gender | Culprit drug | LTT results | Prick test results | Intradermal test results | Patch test results |
---|---|---|---|---|---|---|---|
1
| 15 | female | amoxicillin/clavulanic acid | Negative | Negative |
PPL 1:100 and 1:10 Positive
| Not performed |
2
| 19 | female | amoxicillin | Negative | Negative |
MDM undiluted Positive
| Not performed |
3
| 29 | female | amoxicillin/clavulanic acid | Negative | Negative |
PPL 1:10 Positive
| Not performed |
4
| 23 | male | amoxicillin/clavulanic acid | Negative | Negative |
MDM 1:100 and 1:10 Positive
| Not performed |
5 | 35 | male | amoxicillin/clavulanic acid | Negative | Negative | Negative | Negative |
6 | 24 | female | amoxicillin/clavulanic acid | Negative | Negative | Negative | Negative |
7 | 21 | male | amoxicillin | Negative | Not performed | Not performed | Not performed |
8 | 20 | female | amoxicillin/clavulanic acid | Negative | Not performed | Not performed | Not performed |
9 | 16 | male | amoxicillin/clavulanic acid | Negative | Not performed | Not performed | Not performed |
10 | 27 | male | amoxicillin/clavulanic acid; cefixime | Positive: cefixime | Not performed | Not performed | Not performed |